ERBB2 and adrenal cortex carcinoma: For instance, the HER2 overexpression rate was reported to vary between 38% to 67% in mucoepidermoid carcinomas (MEC) and 30% to 77% in adenoid cystic carcinomas (ACC) in different studies.